LINCOLN PHARMACEUTICALS
Back to Cashflow Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹106 Cr | ₹93 Cr | ₹63 Cr | ₹39 Cr | ₹76 Cr |
What is the latest Cash Flow from Operating Activities ratio of LINCOLN PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹106 Cr |
| Mar2025 | ₹93 Cr |
| Mar2024 | ₹63 Cr |
| Mar2023 | ₹39 Cr |
| Mar2022 | ₹76 Cr |
How is Cash Flow from Operating Activities of LINCOLN PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹106 Cr | 14.35 | |
| Mar2025 | ₹93 Cr | 47.14 | |
| Mar2024 | ₹63 Cr | 61.01 | |
| Mar2023 | ₹39 Cr | -48.43 | |
| Mar2022 | ₹76 Cr | - | |
Compare Cash Flow from Operating Activities of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,041.4 Cr | 1.5% | -6.8% | -2.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹454,914.0 Cr | 7.3% | 8.4% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹300,380.0 Cr | 15.3% | 24.1% | 63% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,169.0 Cr | 1% | 2.5% | 33.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,933.0 Cr | 1% | 15.9% | 14% | Stock Analytics | |
| CIPLA | ₹114,478.0 Cr | 0.4% | 7.9% | -6.2% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | 1.5% |
-6.8% |
-2.2% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses